Literature DB >> 22550329

Behavioural activation: history, evidence and promise.

Jonathan W Kanter, Ajeng J Puspitasari, Maria M Santos, Gabriela A Nagy.   

Abstract

Behavioural activation holds promise to reduce the global burden of depression as a treatment approach that is effective, easy to teach, scalable and acceptable to providers and patients across settings and cultures. This editorial reviews the history of behavioural activation, what it is, current evidence for its use and future directions.

Entities:  

Mesh：

Year:  2012        PMID： 22550329     DOI： 10.1192/bjp.bp.111.103390

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  12 in total

1.  CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial.

Authors:  F Fonseca; J I Mestre-Pintó; M P Schaub; C Baumgartner; M Alias-Ferri; M Torrens
Journal:  Trials       Date:  2022-06-22       Impact factor: 2.728

2.  A client-level session-by-session evaluation of behavioral activation's mechanism of action.

Authors:  Maria M Santos; James R Rae; Gabriela A Nagy; Katherine E Manbeck; Gabriela Diéguez Hurtado; Paul West; Azara Santiago-Rivera; Jonathan W Kanter
Journal:  J Behav Ther Exp Psychiatry       Date:  2016-07-07

3.  Behavioural activation therapy for depression in adults with non-communicable diseases.

Authors:  Eleonora Uphoff; Malini Pires; Corrado Barbui; Deepa Barua; Rachel Churchill; Doriana Cristofalo; David Ekers; Edward Fottrell; Papiya Mazumdar; Marianna Purgato; Rusham Rana; Judy Wright; Najma Siddiqi
Journal:  Cochrane Database Syst Rev       Date:  2020-08-06

4.  Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis.

Authors:  Joachim Ahlers; Christian Baumgartner; Mareike Augsburger; Andreas Wenger; Doris Malischnig; Nikolaos Boumparis; Thomas Berger; Lars Stark; David D Ebert; Severin Haug; Michael P Schaub
Journal:  J Med Internet Res       Date:  2022-04-20       Impact factor: 7.076

5.  An overview of systematic reviews on mental health promotion, prevention, and treatment of common mental disorders for refugees, asylum seekers, and internally displaced persons.

Authors:  Eleonora Uphoff; Lindsay Robertson; Baltica Cabieses; Francisco J Villalón; Marianna Purgato; Rachel Churchill; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2020-09-04

6.  Behavioral activation for dementia caregivers: scheduling pleasant events and enhancing communications.

Authors:  Alma Au; Dolores Gallagher-Thompson; Meng-Kong Wong; Jess Leung; Wai-Chi Chan; Chun Chung Chan; Hui-Jing Lu; Man Kin Lai; Kevin Chan
Journal:  Clin Interv Aging       Date:  2015-03-26       Impact factor: 4.458

7.  Guided Act and Feel Indonesia (GAF-ID) - Internet-based behavioral activation intervention for depression in Indonesia: study protocol for a randomized controlled trial.

Authors:  Retha Arjadi; Maaike H Nauta; Willem F Scholte; Steven D Hollon; Neerja Chowdhary; Angela O Suryani; Claudi L H Bockting
Journal:  Trials       Date:  2016-09-17       Impact factor: 2.279

8.  Behavioural Activation Therapy for Depression after Stroke (BEADS): a study protocol for a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression.

Authors:  Shirley A Thomas; Elizabeth Coates; Roshan das Nair; Nadina B Lincoln; Cindy Cooper; Rebecca Palmer; Stephen J Walters; Nicholas R Latimer; Timothy J England; Laura Mandefield; Timothy Chater; Patrick Callaghan; Avril E R Drummond
Journal:  Pilot Feasibility Stud       Date:  2016-08-10

9.  The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial.

Authors:  Manuel Amann; Severin Haug; Andreas Wenger; Christian Baumgartner; David D Ebert; Thomas Berger; Lars Stark; Marc Walter; Michael P Schaub
Journal:  JMIR Res Protoc       Date:  2018-01-31

10.  Comparing a mindfulness- and CBT-based guided self-help Internet- and mobile-based intervention against a waiting list control condition as treatment for adults with frequent cannabis use: a randomized controlled trial of CANreduce 3.0.

Authors:  Michelle Dey; Andreas Wenger; Christian Baumgartner; Ute Herrmann; Mareike Augsburger; Severin Haug; Doris Malischnig; Michael P Schaub
Journal:  BMC Psychiatry       Date:  2022-03-24       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.